首页> 外文期刊>artificial organs >C3a and C5a Anaphylatoxins Bind to Heparin‐Based Sorbent in Low Density Lipoprotein Apheresis: In Vitro and In Vivo Investigations
【24h】

C3a and C5a Anaphylatoxins Bind to Heparin‐Based Sorbent in Low Density Lipoprotein Apheresis: In Vitro and In Vivo Investigations

机译:C3a and C5a Anaphylatoxins Bind to Heparin‐Based Sorbent in Low Density Lipoprotein Apheresis: In Vitro and In Vivo Investigations

获取原文
           

摘要

Abstract:Plasmasorption on a heparin‐based sorbent was performed in vitro. It demonstrated affinity of the C3a and C5a anaphylatoxins for the sorbent: C3a was removed almost completely (97), and the C5a concentration decreased on average by 55. The plasma level of C3a and C5a complement components was also monitored during the procedure of clinical extracorporeal low density lipoprotein (LDL) apheresis on the sorbent in patients with familial hypercholesterolemia. A two‐ to threefold increase in C3a (up to 1,500 ng/ml) was observed after plasma separation by the IBM 2997 cell sorter. Subsequent processing of the plasma through the column led to the low level of C3a detected (less than 50 ng/ml), demonstrating significant uptake of C3a by the sorbent column. The removed C3a was found in the eluate obtained after regeneration of the sorbent with 2MNaCl solution. No significant increase in C5a was found during the procedure. Nevertheless, some C5a was detected in the eluate from the sorbent. The content of C3a and C5a in patients' blood after the treatment was approximately the same as it was initially, 200–500 ng/ml for C3a and less than 10 ngiml for C5a. The removal of C3a and C5a anaphylatoxins by heparin‐based sorbent should be regarded as an advantage of this type of plasma
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号